Inactivating UBE2M impacts the DNA damage response and genome integrity involving multiple Cullin ligases

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Cukras, Scott ^a   Morffy, Nicholas ^a   Ohn, Takbum ^b   Kee, Younghoon ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Chosun University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FACTOR; CLASPIN; CULLIN 1 LIGASE; CULLIN 2 LIGASE; CULLIN 4 LIGASE; CULLIN LIGASE; LIGASE; PROTEIN P21; RAD51 PROTEIN; REGULATOR PROTEIN; REPLICATION LICENSING FACTOR CDT1; REPLICATION LICENSING FACTOR CDT2; SMALL INTERFERING RNA; UBE2M; UBIQUITIN CONJUGATING ENZYME E2; UNCLASSIFIED DRUG; CDT1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CUL2 PROTEIN, HUMAN; CULLIN; DTL PROTEIN, HUMAN; NUCLEAR PROTEIN; UBE2M PROTEIN, HUMAN; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; G2 PHASE CELL CYCLE CHECKPOINT; GENOMIC INSTABILITY; NEDDYLATION; CELL CYCLE; CELL CYCLE CHECKPOINT; CELL LINE; DRUG EFFECTS; GENE SILENCING; GENETICS; HUMAN; METABOLISM;

CELL CYCLE; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE; CULLIN PROTEINS; DNA DAMAGE; DNA REPAIR; GENE SILENCING; GENOMIC INSTABILITY; HUMANS; NUCLEAR PROTEINS; RAD51 RECOMBINASE; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITIN-PROTEIN LIGASES;

EID: 84904263051     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101844     Document Type: Article

References (60)

1. Huang DT, Ayrault O, Hunt HW, Taherbhoy AM, Duda DM, et al. (2009) E2- RING expansion of the NEDD8 cascade confers specificity to cullin modification. Mol Cell 33: 483-495.
2. Ma T, Chen Y, Zhang F, Yang CY, Wang S, et al. (2013) RNF111-dependent neddylation activates DNA damage-induced ubiquitination. Mol Cell 49: 897- 907.
3. Xirodimas DP, Saville MK, Bourdon JC, Hay RT, Lane DP (2004) Mdm2- mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell 118: 83-97. (Pubitemid 38902816)
4. Duda DM, Scott DC, Calabrese MF, Zimmerman ES, Zheng N, et al. (2011) Structural regulation of cullin-RING ubiquitin ligase complexes. Curr Opin Struct Biol 21: 257-264.
5. Deshaies RJ, Emberley ED, Saha A (2010) Control of cullin-ring ubiquitin ligase activity by nedd8. Subcell Biochem 54: 41-56.
6. Xu L, Wei Y, Reboul J, Vaglio P, Shin TH, et al. (2003) BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. Nature 425: 316-321. (Pubitemid 37158409)
7. Lee J, Zhou P (2007) DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase. Mol Cell 26: 775-780. (Pubitemid 46921011)
8. Kamura T, Maenaka K, Kotoshiba S, Matsumoto M, Kohda D, et al. (2004) VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev 18: 3055-3065. (Pubitemid 39658174)
9. Winston JT, Koepp DM, Zhu C, Elledge SJ, Harper JW (1999) A family of mammalian F-box proteins. Curr Biol 9: 1180-1182. (Pubitemid 29527104)
10. Jin J, Cardozo T, Lovering RC, Elledge SJ, Pagano M, et al. (2004) Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev 18: 2573-2580. (Pubitemid 39453096)
11. Li JM, Jin J (2012) CRL Ubiquitin Ligases and DNA Damage Response. Front Oncol 2: 29.
12. Zhao Y, Morgan MA, Sun Y (2014) Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy. Antioxid Redox Signal.
13. Silverman JS, Skaar JR, Pagano M (2012) SCF ubiquitin ligases in the maintenance of genome stability. Trends Biochem Sci 37: 66-73.
14. Busino L, Donzelli M, Chiesa M, Guardavaccaro D, Ganoth D, et al. (2003) Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. Nature 426: 87-91. (Pubitemid 37432546)
15. Kee Y, Kim JM, D'Andrea AD (2009) Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis. Genes Dev 23: 555-560.
16. Peschiaroli A, Dorrello NV, Guardavaccaro D, Venere M, Halazonetis T, et al. (2006) SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. Mol Cell 23: 319-329. (Pubitemid 44128849)
17. Mailand N, Bekker-Jensen S, Bartek J, Lukas J (2006) Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress. Mol Cell 23: 307-318. (Pubitemid 44128852)
18. Wang Z, Inuzuka H, Zhong J, Fukushima H, Wan L, et al. (2012) DNA damage-induced activation of ATM promotes beta-TRCP-mediated Mdm2 ubiquitination and destruction. Oncotarget 3: 1026-1035.
19. Watanabe N, Arai H, Nishihara Y, Taniguchi M, Hunter T, et al. (2004) M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP. Proc Natl Acad Sci U S A 101: 4419-4424. (Pubitemid 38437427)
20. Jin J, Shirogane T, Xu L, Nalepa G, Qin J, et al. (2003) SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev 17: 3062-3074. (Pubitemid 38040770)
21. Sugasawa K, Okuda Y, Saijo M, Nishi R, Matsuda N, et al. (2005) UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex. Cell 121: 387-400. (Pubitemid 40692299)
22. Wang H, Zhai L, Xu J, Joo HY, Jackson S, et al. (2006) Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase facilitates cellular response to DNA damage. Mol Cell 22: 383-394. (Pubitemid 44308132)
23. Abbas T, Shibata E, Park J, Jha S, Karnani N, et al. (2010) CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation. Mol Cell 40: 9-21.
24. Arias EE, Walter JC (2005) Replication-dependent destruction of Cdt1 limits DNA replication to a single round per cell cycle in Xenopus egg extracts. Genes Dev 19: 114-126. (Pubitemid 40095821)
25. Centore RC, Havens CG, Manning AL, Li JM, Flynn RL, et al. (2010) CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase. Mol Cell 40: 22-33.
26. Higa LA, Mihaylov IS, Banks DP, Zheng J, Zhang H (2003) Radiation-mediated proteolysis of CDT1 by CUL4-ROC1 and CSN complexes constitutes a new checkpoint. Nat Cell Biol 5: 1008-1015. (Pubitemid 37406915)
27. Hu J, McCall CM, Ohta T, Xiong Y (2004) Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damage. Nat Cell Biol 6: 1003-1009. (Pubitemid 39359854)
28. Jin J, Arias EE, Chen J, Harper JW, Walter JC (2006) A family of diverse Cul4- Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol Cell 23: 709-721. (Pubitemid 44292562)
29. Jorgensen S, Eskildsen M, Fugger K, Hansen L, Larsen MS, et al. (2011) SET8 is degraded via PCNA-coupled CRL4(CDT2) ubiquitylation in S phase and after UV irradiation. J Cell Biol 192: 43-54.
30. Kim Y, Starostina NG, Kipreos ET (2008) The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Genes Dev 22: 2507-2519.
31. Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, et al. (2009) An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458: 732-736.
32. Lin JJ, Milhollen MA, Smith PG, Narayanan U, Dutta A (2010) NEDD8- targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells. Cancer Res 70: 10310-10320.
33. Yang D, Tan M, Wang G, Sun Y (2012) The p21-dependent radiosensitization of human breast cancer cells by MLN4924, an investigational inhibitor of NEDD8 activating enzyme. PLoS One 7: e34079.
34. Jia L, Li H, Sun Y (2011) Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression. Neoplasia 13: 561-569.
35. Kee Y, Huang M, Chang S, Moreau LA, Park E, et al. (2012) Inhibition of the Nedd8 system sensitizes cells to DNA interstrand cross-linking agents. Mol Cancer Res 10: 369-377.
36. Nawrocki ST, Kelly KR, Smith PG, Espitia CM, Possemato A, et al. (2013) Disrupting protein NEDDylation with MLN4924 is a novel strategy to target cisplatin resistance in ovarian cancer. Clin Cancer Res 19: 3577-3590.
37. Jazaeri AA, Shibata E, Park J, Bryant JL, Conaway MR, et al. (2013) Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924. Mol Cancer Ther 12: 1958-1967.
38. Garcia K, Blank JL, Bouck DC, Liu XJ, Sappal DS, et al. (2014) Nedd8- Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2 and Chromatin Dynamics Pathways. Mol Cancer Ther.
39. Jacquemont C, Taniguchi T (2007) Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Cancer Res 67: 7395-7405. (Pubitemid 47206570)
40. Murakawa Y, Sonoda E, Barber LJ, Zeng W, Yokomori K, et al. (2007) Inhibitors of the proteasome suppress homologous DNA recombination in mammalian cells. Cancer Res 67: 8536-8543. (Pubitemid 47437428)
41. Johnson N, Li YC, Walton ZE, Cheng KA, Li D, et al. (2011) Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition. Nat Med 17: 875-882.
42. Dutta P, Bui T, Bauckman KA, Keyomarsi K, Mills GB, et al. (2013) EVI1 splice variants modulate functional responses in ovarian cancer cells. Mol Oncol 7: 647-668.
43. Nakanishi K, Yang YG, Pierce AJ, Taniguchi T, Digweed M, et al. (2005) Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc Natl Acad Sci U S A 102: 1110-1115. (Pubitemid 40170734)
44. Gunn A, Stark JM (2012) I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double strand breaks. Methods Mol Biol 920: 379-391.
45. Wada H, Yeh ET, Kamitani T (2000) A dominant-negative UBC12 mutant sequesters NEDD8 and inhibits NEDD8 conjugation in vivo. J Biol Chem 275: 17008-17015. (Pubitemid 30398942)
46. Yarde DN, Oliveira V, Mathews L, Wang X, Villagra A, et al. (2009) Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma. Cancer Res 69: 9367-9375.
47. Cron KR, Zhu K, Kushwaha DS, Hsieh G, Merzon D, et al. (2013) Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer. PLoS One 8: e73710.
48. Yaron A, Hatzubai A, Davis M, Lavon I, Amit S, et al. (1998) Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature 396: 590- 594.
49. Carrano AC, Eytan E, Hershko A, Pagano M (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1: 193- 199.
50. Wada H, Yeh ET, Kamitani T (1999) Identification of NEDD8-conjugation site in human cullin-2. Biochem Biophys Res Commun 257: 100-105. (Pubitemid 29299054)
51. Starostina NG, Simpliciano JM, McGuirk MA, Kipreos ET (2010) CRL2(LRR- 1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells. Dev Cell 19: 753-764.
52. Havens CG, Walter JC (2011) Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase. Genes Dev 25: 1568-1582.
53. Sorensen CS, Syljuasen RG, Lukas J, Bartek J (2004) ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage. Cell Cycle 3: 941-945. (Pubitemid 40179476)
54. Moss J, Tinline-Purvis H, Walker CA, Folkes LK, Stratford MR, et al. (2010) Break-induced ATR and Ddb1-Cul4(Cdt)(2) ubiquitin ligase-dependent nucleotide synthesis promotes homologous recombination repair in fission yeast. Genes Dev 24: 2705-2716.
55. Bacquin A, Pouvelle C, Siaud N, Perderiset M, Salome-Desnoulez S, et al. (2013) The helicase FBH1 is tightly regulated by PCNA via CRL4(Cdt2)- mediated proteolysis in human cells. Nucleic Acids Res 41: 6501-6513.
56. Salon C, Brambilla E, Brambilla C, Lantuejoul S, Gazzeri S, et al. (2007) Altered pattern of Cul-1 protein expression and neddylation in human lung tumours: relationships with CAND1 and cyclin E protein levels. J Pathol 213: 303-310. (Pubitemid 350074020)
57. Chen LC, Manjeshwar S, Lu Y, Moore D, Ljung BM, et al. (1998) The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers. Cancer Res 58: 3677-3683. (Pubitemid 28376568)
58. Yasui K, Arii S, Zhao C, Imoto I, Ueda M, et al. (2002) TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology 35: 1476-1484. (Pubitemid 34966902)
59. Bai J, Zhou Y, Chen G, Zeng J, Ding J, et al. (2011) Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer. Hum Pathol 42: 375-383.
60. Bo H, Ghazizadeh M, Shimizu H, Kurihara Y, Egawa S, et al. (2004) Effect of ionizing irradiation on human esophageal cancer cell lines by cDNA microarray gene expression analysis. J Nippon Med Sch 71: 172-180. (Pubitemid 38899861)